Summary of Anti-Inflammatory Prevents Heart Attacks

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

Anti-Inflammatory Prevents Heart Attacks summary
Start getting smarter:
or see our plans

Rating

7 Overall

7 Importance

7 Innovation

7 Style


Recommendation

Would you pay a premium for a drug that could reduce heart disease and lung cancer? Early evidence suggests that a juvenile arthritis drug might offer hope to people at high risk for heart attacks and strokes. The anti-inflammatory properties of canakinumab might prevent atherosclerosis that leads to heart attacks. getAbstract suggests this article to those with an interest in the inflammation theory of heart disease.

In this summary, you will learn

  • Why the modest results of the canakinumab trial are important,
  • How canakinumab works and
  • Where the anti-inflammatory drug is in its experimental stages.
 

About the Author

Jennifer Couzin-Frankel, a Science Magazine staff writer since 2002, attended Harvard University.

 

Summary

What is the connection between inflammation and heart attacks?

Immune cells such as macrophages, a type of white blood cell, set off a complex set of events. These immune cells trigger arterial plaque by migrating into blood vessels. When arterial plaque builds up, it can block and rupture resulting in heart attacks.


More on this topic

Customers who read this summary also read

Killer Clones
Killer Clones
8
The Greatest Hits of the Human Genome
The Greatest Hits of the Human Genome
8
The Lucky Years
The Lucky Years
8
The Power of the Placebo
The Power of the Placebo
8
I Contain Multitudes
I Contain Multitudes
9
In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’
In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’
9

Related Channels

Comment on this summary